Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors

Purpose: The purposes of this study were to determine whether the presence of upper extremity chemotherapy-induced peripheral neuropathy (CIPN) symptoms (burning, pins/needles, numbness, pain, and skin crawls) among breast cancer survivors (BCS) varied according to age (≤45 years or 55–70 years) and...

Full description

Bibliographic Details
Main Authors: Susan Storey, Andrea Cohee, Diane Von Ah, Eric Vachon, Noah R. Zanville, Patrick O. Monahan, Timothy E. Stump, Victoria L. Champion
Format: Article
Language:English
Published: Advocate Aurora Health 2020-10-01
Series:Journal of Patient-Centered Research and Reviews
Subjects:
Online Access:https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1757&context=jpcrr
_version_ 1811174143233622016
author Susan Storey
Andrea Cohee
Diane Von Ah
Eric Vachon
Noah R. Zanville
Patrick O. Monahan
Timothy E. Stump
Victoria L. Champion
author_facet Susan Storey
Andrea Cohee
Diane Von Ah
Eric Vachon
Noah R. Zanville
Patrick O. Monahan
Timothy E. Stump
Victoria L. Champion
author_sort Susan Storey
collection DOAJ
description Purpose: The purposes of this study were to determine whether the presence of upper extremity chemotherapy-induced peripheral neuropathy (CIPN) symptoms (burning, pins/needles, numbness, pain, and skin crawls) among breast cancer survivors (BCS) varied according to age (≤45 years or 55–70 years) and to examine age group differences in upper extremity CIPN symptom distress. Methods: The study was a secondary analysis of younger (n = 505) and older (n = 622) BCS. Inclusion criteria were age of ≤45 years or 55–70 years; patient at 3–8 years postdiagnosis; patient received the chemotherapy regimen of paclitaxel, doxorubicin, and cyclophosphamide; and patient did not have recurrence. The Symptom Survivor Checklist was used to assess presence and distress of upper extremity CIPN symptoms. Analyses explored whether age group predicted CIPN symptom presence and distress while controlling for sociodemographic and medical variables. Results: Older BCS reported fewer pins/needles, numbness, and pain symptoms (odds ratios: 0.623–0.751). Heart disease (odds ratios: 1.59–1.70) and progesterone-negative breast cancer (odds ratio: 0.663) were significantly associated with one or more CIPN symptoms. Symptom distress ratings did not differ by age groups; both age groups indicated distress from CIPN symptoms, with 25% or more reporting distress as “moderately” or “quite a bit.” Conclusions: Younger BCS reported more upper extremity CIPN symptoms. BCS in both groups continued to report bothersome CIPN symptoms years after treatment. Study findings will assist clinicians in identifying BCS at higher risk for upper extremity CIPN as well as inform development of appropriate tailored interventions to mitigate these symptoms and facilitate restoration to age-related baseline function, thereby improving quality of life for BCS.
first_indexed 2024-04-10T17:58:20Z
format Article
id doaj.art-636a9a55f5d44a12bcafd32a6ca1ad96
institution Directory Open Access Journal
issn 2330-0698
language English
last_indexed 2024-04-10T17:58:20Z
publishDate 2020-10-01
publisher Advocate Aurora Health
record_format Article
series Journal of Patient-Centered Research and Reviews
spelling doaj.art-636a9a55f5d44a12bcafd32a6ca1ad962023-02-02T16:47:12ZengAdvocate Aurora HealthJournal of Patient-Centered Research and Reviews2330-06982020-10-017429530310.17294/2330-0698.1757Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer SurvivorsSusan Storey0Andrea Cohee1Diane Von Ah2Eric Vachon3Noah R. Zanville4Patrick O. Monahan5Timothy E. Stump6Victoria L. Champion 7Indiana University School of Nursing, Indianapolis, INIndiana University School of Nursing, Indianapolis, INIndiana University School of Nursing, Indianapolis, INIndiana University School of Nursing, Indianapolis, INMiami Cancer Institute, Baptist Health South Florida, Miami, FLIndiana University School of Medicine, Indianapolis, IN; Richard M. Fairbanks School of Public Health, Indianapolis, INIndiana University School of Medicine, Indianapolis, INIndiana University School of Nursing, Indianapolis, INPurpose: The purposes of this study were to determine whether the presence of upper extremity chemotherapy-induced peripheral neuropathy (CIPN) symptoms (burning, pins/needles, numbness, pain, and skin crawls) among breast cancer survivors (BCS) varied according to age (≤45 years or 55–70 years) and to examine age group differences in upper extremity CIPN symptom distress. Methods: The study was a secondary analysis of younger (n = 505) and older (n = 622) BCS. Inclusion criteria were age of ≤45 years or 55–70 years; patient at 3–8 years postdiagnosis; patient received the chemotherapy regimen of paclitaxel, doxorubicin, and cyclophosphamide; and patient did not have recurrence. The Symptom Survivor Checklist was used to assess presence and distress of upper extremity CIPN symptoms. Analyses explored whether age group predicted CIPN symptom presence and distress while controlling for sociodemographic and medical variables. Results: Older BCS reported fewer pins/needles, numbness, and pain symptoms (odds ratios: 0.623–0.751). Heart disease (odds ratios: 1.59–1.70) and progesterone-negative breast cancer (odds ratio: 0.663) were significantly associated with one or more CIPN symptoms. Symptom distress ratings did not differ by age groups; both age groups indicated distress from CIPN symptoms, with 25% or more reporting distress as “moderately” or “quite a bit.” Conclusions: Younger BCS reported more upper extremity CIPN symptoms. BCS in both groups continued to report bothersome CIPN symptoms years after treatment. Study findings will assist clinicians in identifying BCS at higher risk for upper extremity CIPN as well as inform development of appropriate tailored interventions to mitigate these symptoms and facilitate restoration to age-related baseline function, thereby improving quality of life for BCS.https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1757&context=jpcrrbreast cancersurvivorshipchemotherapy-induced peripheral neuropathyupper extremitysymptom bothersymptom distress
spellingShingle Susan Storey
Andrea Cohee
Diane Von Ah
Eric Vachon
Noah R. Zanville
Patrick O. Monahan
Timothy E. Stump
Victoria L. Champion
Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
Journal of Patient-Centered Research and Reviews
breast cancer
survivorship
chemotherapy-induced peripheral neuropathy
upper extremity
symptom bother
symptom distress
title Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
title_full Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
title_fullStr Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
title_full_unstemmed Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
title_short Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors
title_sort presence and distress of chemotherapy induced peripheral neuropathy symptoms in upper extremities of younger and older breast cancer survivors
topic breast cancer
survivorship
chemotherapy-induced peripheral neuropathy
upper extremity
symptom bother
symptom distress
url https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1757&context=jpcrr
work_keys_str_mv AT susanstorey presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT andreacohee presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT dianevonah presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT ericvachon presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT noahrzanville presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT patrickomonahan presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT timothyestump presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors
AT victorialchampion presenceanddistressofchemotherapyinducedperipheralneuropathysymptomsinupperextremitiesofyoungerandolderbreastcancersurvivors